SIC
REGN icon

Salem Investment Counselors’s Regeneron Pharmaceuticals REGN Stock Holding History

Salem Investment Counselors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$2.14K – 1253
2024
Q4 		$2.14K Hold
3
– – ﹤0.01% 1011
2024
Q3 		$3.15K Sell
3
-15
-83% -$16.7K ﹤0.01% 975
2024
Q2 		$18.9K Hold
18
– – ﹤0.01% 726
2024
Q1 		$17.3K Hold
18
– – ﹤0.01% 742
2023
Q4 		$15.8K Hold
18
– – ﹤0.01% 732
2023
Q3 		$14.8K Hold
18
– – ﹤0.01% 723
2023
Q2 		$12.9K Sell
18
-150
-89% -$116K ﹤0.01% 780
2023
Q1 		$138K Sell
168
-105
-38% -$79.2K 0.01% 378
2022
Q4 		$197K Buy
273
+53
+24% +$39.1K 0.01% 329
2022
Q3 		$152K Sell
220
-855
-80% -$538K 0.01% 341
2022
Q2 		$635K Buy
1,075
+92
+9% +$59.8K 0.03% 216
2022
Q1 		$687K Sell
983
-100
-9% -$63.3K 0.03% 223
2021
Q4 		$684K Buy
1,083
+250
+30% +$154K 0.02% 240
2021
Q3 		$504K Buy
833
+286
+52% +$178K 0.03% 245
2021
Q2 		$306K Buy
547
+183
+50% +$92.7K 0.02% 285
2021
Q1 		$172K Buy
+364
New +$177K 0.01% 302
2017
Q4 		– Sell
-5
Closed -$2K – 576
2017
Q3 		$2K Sell
5
-4
-44% -$1.9K ﹤0.01% 525
2017
Q2 		$4K Buy
+9
New +$3.94K ﹤0.01% 537
2017
Q1 		– Sell
-6
Closed -$2K – 631
2016
Q4 		$2K Buy
+6
New +$2.28K ﹤0.01% 623

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Salem Investment Counselors's REGN Position: Q1 2025 in Review

Salem Investment Counselors sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 3 shares — an estimated $2.14K sold.

Salem Investment Counselors first reported a position in REGN in Q4 2016 and held it in 19 quarters. The position peaked at $687K in Q1 2022. 1,291 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Salem Investment Counselors reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Salem Investment Counselors sold 3 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $2.14K.
  • Salem Investment Counselors first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Salem Investment Counselors's Regeneron Pharmaceuticals position peaked at $687K in Q1 2022.
  • 1,291 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Salem Investment Counselors's 13F filing for Q1 2025, filed 16 Apr 2025.